Kevin Curran is a research biologist and educator in the field of advanced medicine. He received his PhD in Molecular Biology from the University of Washington in Seattle. As an academic scientist, Dr. Curran performed cancer research at Memorial Sloan Kettering, stem cell biology at UCSF, and behavioral neuroscience as a post-doc at the Salk Institute. In the life science industry, Dr. Curran has worked for Bristol Meyers, Biogen, Sarepta, and Caring Cross to assist in their pursuit of cell and gene therapies for life-threatening diseases. Dr. Curran is an instructor for Biotech Primer and operates his own biotech consulting firm, BridgePoint Bio.